Sunday, 16 June 2019

Pharma News

  • BMS announces Q2 2012 results

    Pharma |  Company results | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2012

    Singapore: Bristol-Myers Squibb (BMS) reported results for the second quarter (Q2) of 2012 and also adjusted its GAAP EPS guidance range and confirmed its non-GAAP EPS guidance range for 20...Read more

  • US FDA approves Suprax 400 mg by Lupin

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Mumbai: Lupin Pharmaceuticals, a subsidiary of India-based Lupin, has received approval for Suprax (Cefixime) Capsules 400 mg from the US Food and Drugs Administration (FDA). A statement re...Read more

  • Bristol-Myers Squibb reveals new grants for Hepatitis in India, China

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 30, 2012: The Bristol-Myers Squibb Foundation has awarded four new grants totaling US $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatiti...Read more

  • Tiyanyin pharma all set for GMP inspection

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more

  • Simcere, Zhuhai enter share transfer agreement

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more

  • Another Wockhardt plant banned by the US FDA

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

    Mumbai: New product launch approvals of Wockhardt are going to be delayed as a second plant operated by the generic drug maker was hit by the US FDA import alert. This ban results in detent...Read more

  • SFDA reports high chromium in Biostar's drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 01, 2012: China based Biostar Pharmaceuticals has acknowledged the finding of  chromium content higher than edible gelatin from a batch of its Xin Aoxing capsules following...Read more

  • Orodispersible technology

    Pharma |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

    The orodispersible tablet (ODT) technology offers advantages over the traditional dosage formulations as they allow easy swallowing without the use of water in paediatrics and geriatrics pa...Read more

  • Ambrx, Zhejiang, WuXi to develop cancer drug in China

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jun, 2013

    Singapore: US-based Ambrx and China-based Zhejiang Medicine (ZMC) announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally devel...Read more

  • Amgen CEO speaks of firm's grand entry into Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    The world's largest biotechnology company Amgen entered into a long-term collaboration with Astellas Pharma in May this year, and is set to form a joint venture in Tokyo, Amgen Astellas Bio...Read more

  • Strand life sciences launches a new method for monitoring cancer

    Pharma |  News | 0 Comment | 12 Apr, 2017

    Strand Life Sciences have launched their Liquid Biopsy test portfolio ‘STRAND LB' that provides highly sensitive detection of tumor traces from a simple blood draw. This powerful tool...Read more

  • Novartis in troubled waters!

    Pharma |  Analysis | 0 Comment | 10 Mar, 2017

    Swiss pharma giant Novartis has been imposed a fine of 200 million won ($174,628) by the South Korean Health Ministry for allegedly paying kickbacks to promote sales of its medicines. The c...Read more

  • Takeda completes acquisition of ARIAD Pharmaceuticals

    Pharma |  News | 0 Comment | 21 Feb, 2017

    Takeda Pharmaceutical Company Limited  announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. for $24.00 per share in cash.  “We are very pleased to hav...Read more

  • New CoolPal Vertos Advance launched by Pelican BioThermal

    Pharma |  News | 0 Comment | 19 Jan, 2017

    US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-controlled packaging solutions serving the life sciences industry has r...Read more

  • Sun Pharma to acquire Novartis’s cancer drug Odomzo for $175m

    Pharma |  News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2017

    Sun Pharmaceutical Industries Ltd is planning to acquire Novartis AG branded cancer drug Odomzo for $175 million. Under the agreement, Sun Pharma will get global marketing rights for the pr...Read more

  • Kite Pharma joins hands with Daiichi Sankyo for cancer med

    Pharma |  News | 0 Comment | 10 Jan, 2017

    Singapore: US based Kite Pharma announced that it has joined hands with Japanese drug giant Daiichi Sankyo to co-develop and commercialize its cancer treatment therapy in Japan. The drug is...Read more

  • Sun Pharma to acquire branded oncology product Odomzo for global markets

    Pharma |  News | 0 Comment | 23 Dec, 2016

    Sun Pharma  announced its plans to acquire a branded oncology product, Odomzo, from Novartis. The agreement has been signed between subsidiaries of both the companies and will close f...Read more

  • CEPI board meeting with a focus on identifying disease priorities and future strategy

    Pharma |  News | 0 Comment | 19 Dec, 2016

    The Department of Biotechnology (DBT) will be partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI) which is a new global alliance among governments, industries, acad...Read more

Podcast

 

Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls